Istituto Scientifico Romagnolo per Studio e Cura Tumori IRST ( Site 0403)

Meldola, Forli-Cesena 47014

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716) — Running, not enrolling